Mallory Smith
Adult Health · Louisville, KYNPI 1609334630
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,146 and has fallen 94.0% since, to $68 in 2025.
Across 77 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$231
- AstraZeneca$225
- Eisai Inc.$162
- Neurocrine Biosciences, Inc.$150
- SK Life Science, Inc.$144
- AbbVie$133
- plus $830 from 15 others
What the payments were for
- Food & beverage$1,876100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 8 | $231 |
| AstraZeneca(2 entities) | 9 | $225 |
| Eisai Inc. | 6 | $162 |
| Neurocrine Biosciences, Inc. | 5 | $150 |
| SK Life Science, Inc. | 7 | $144 |
| AbbVie | 6 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $126 |
| Boston Scientific | 3 | $123 |
| Teva Pharmaceuticals USA, Inc. | 5 | $122 |
| Novartis | 5 | $114 |
| EMD Serono, Inc. | 4 | $90 |
| Averitas Pharma Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Viiv Healthcare Company | 1 | $26 |
| Livanova USA, Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 2 | $23 |
| Curonix LLC | 1 | $19 |
| Nevro Corp. | 1 | $17 |
| Piramal Critical Care | 1 | $17 |
| Genentech USA, Inc. | 1 | $14 |
How this compares
$1,876 in reported general payments places this provider in the 75th percentile of 170 adult health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 14 | $10,812 |
| Emgality PenGalcanezumab-Gnlm | 11 | $7,701 |
| Tegretol XrCarbamazepine | 14 | $4,191 |
| Memantine Hcl | 121 | $2,544 |
| Carbamazepine ErCarbamazepine | 24 | $2,369 |
| Donepezil Hcl | 165 | $1,368 |
| Gabapentin | 70 | $1,008 |
| Pregabalin | 36 | $935 |
| Pyridostigmine Bromide | 11 | $834 |
| Primidone | 46 | $797 |
| Divalproex Sodium | 14 | $691 |
| Levetiracetam | 32 | $653 |
| Phenobarbital | 13 | $503 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 46 | $488 |
| Atorvastatin Calcium | 45 | $465 |
Paid to pharmacies, not to this prescriber.
Other adult health in Louisville
- Stephanie FlaspoehlerLouisville$174K
- Heidi GalloLouisville$15K
- Karen EastridgeLouisville$10K
- Barbara CarpenterLouisville$8K
- Loren GarzaLouisville$6K
- Kelly MikeLouisville$4K
- Layla Al-ShamiLouisville$3K
- Brittany McWhorterLouisville$3K
- Lahoma PratherLouisville$2K
- William NapierLouisville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.